Svra stock
NewsSee all news. 02 April 2020 Savara Obtains Global Rights to Develop and Commercialize Apulmiq. Management to Host Conference Call / Webcast with Bronchiectasis Expert Dr. James Chalmers Savara Inc. (NASDAQ:SVRA), an orphan lung disease company, today announced the Company has entered into an exclusive license SVRA -- Is Its Stock Price A Worthy Investment? Learn More. Savara, Inc. (SVRA) Company Bio Savara Inc., a clinical-stage specialty pharmaceutical company, focuses on the development and commercialization of novel therapies for the treatment of serious or life-threatening rare respiratory diseases. Read This Before Selling Savara Inc. (NASDAQ:SVRA) Shares ...
These institutions hold a total of 27,756,279 shares. Largest shareholders include Bain Capital Life Sciences Investors, Llc, Farallon Capital Management Llc,
SVRA Savara Inc. Stock Quote - FINVIZ.com Savara Inc. operates as an orphan lung disease company. Its lead product candidate includes Molgradex, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis; and in Phase IIa development stage for treating nontuberculous mycobacterial lung infection. Savara, Inc. - SVRA - Stock Price & News | The Motley Fool Real time Savara, Inc. (SVRA) stock price quote, stock graph, news & analysis. Savara, Inc. - SVRA - Stock Price & News | The Motley Fool Latest Stock Picks SVRA: Savara Inc - Stock Price, Quote and News - CNBC Get Savara Inc (SVRA:NASDAQ) real-time stock quotes, news and financial information from CNBC. Savara Inc. Stock Price (SVRA) | Barron's
Nov 07, 2019 · SVRA, Savara Inc - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines
Mar 31, 2020 (SVRA). Overbought and Oversold levels. The stock has RSI reading of 49.34. RSI gives an indication of the impending reversals or reaction in Savara, Inc. (SVRA) Stock Price, Quote, History & News ...
Savara Inc. Common Stock (SVRA) News Headlines | Nasdaq
SVRA - Stock quote for SAVARA INC. - MSN Money View the latest SVRA stock quote and chart on MSN Money. Dive deeper with interactive charts and top stories of SAVARA INC.. Savara Inc. Common Stock (SVRA) News Headlines | Nasdaq
Events | SVRA
Apr 01, 2020 · Learn about SVRA with our data and independent analysis including price, star rating, valuation, dividends, and financials. Start a 14-day free trial to Morningstar Premium to unlock our take on SVRA. Savara, Inc. (SVRA) News Headlines - NASDAQ.com Savara, Inc. (SVRA) News – Find the latest company news headlines for Savara, Inc. and all the companies you research at NASDAQ.com SVRA Price Target | Savara Stock Forecast & Ratings
Savara Inc SVRA - Quotes, Financials, News, Charts and ... Stocks Rankings for SVRA. U.S. News compares companies to their industry peers based on a variety of company fundamentals, performance metrics and investor preferences to help you find the right Savara +96% premarket on BTD tag for Molgradex for aPAP ... Dec 30, 2019 · Savara (NASDAQ:SVRA) is up 96% premarket in response to its announcement that the FDA has granted Breakthrough Therapy Designation (BTD) for Molgradex, an inhaled formulation of recombinant human Savara, Inc. - TheStreet Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.